MaryAnn Go

527 total citations
3 papers, 195 citations indexed

About

MaryAnn Go is a scholar working on Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, MaryAnn Go has authored 3 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Pathology and Forensic Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in MaryAnn Go's work include HER2/EGFR in Cancer Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). MaryAnn Go is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). MaryAnn Go collaborates with scholars based in Italy, United Kingdom and Argentina. MaryAnn Go's co-authors include Andrew G. Polson, Shang‐Fan Yu, Bing Zheng, John A. Flygare, Susan D. Spencer, Suchit Jhunjhunwala, Robert Cohen, Helga Raab, Jeff Lau and Paul Polakis and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

MaryAnn Go

3 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
MaryAnn Go Italy	2	144	119	65	49	33	3	195
Lauren Harvey United States	6	179 1.2×	64 0.5×	88 1.4×	112 2.3×	45 1.4×	8	258
Kristi Elkins United Kingdom	5	174 1.2×	68 0.6×	103 1.6×	51 1.0×	42 1.3×	8	273
Kevin Dang United States	6	131 0.9×	113 0.9×	36 0.6×	32 0.7×	62 1.9×	14	174
Joseph Kauer Germany	8	107 0.7×	44 0.4×	65 1.0×	58 1.2×	82 2.5×	23	196
Kirsten Achilles Poon United States	6	180 1.3×	142 1.2×	74 1.1×	32 0.7×	40 1.2×	6	278
Shaoyi Li United States	4	123 0.9×	61 0.5×	117 1.8×	116 2.4×	29 0.9×	5	227
Josh Snyder United States	5	122 0.8×	77 0.6×	66 1.0×	17 0.3×	18 0.5×	6	189
Nika M Harutyunyan United States	7	212 1.5×	118 1.0×	124 1.9×	213 4.3×	47 1.4×	14	312
Torben Altmann Germany	5	190 1.3×	66 0.6×	56 0.9×	78 1.6×	131 4.0×	8	253
Gabriel O. Cole United States	4	228 1.6×	43 0.4×	122 1.9×	113 2.3×	79 2.4×	4	280

Countries citing papers authored by MaryAnn Go

Since Specialization

Citations

This map shows the geographic impact of MaryAnn Go's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MaryAnn Go with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MaryAnn Go more than expected).

Fields of papers citing papers by MaryAnn Go

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MaryAnn Go. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MaryAnn Go. The network helps show where MaryAnn Go may publish in the future.

Co-authorship network of co-authors of MaryAnn Go

This figure shows the co-authorship network connecting the top 25 collaborators of MaryAnn Go. A scholar is included among the top collaborators of MaryAnn Go based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MaryAnn Go. MaryAnn Go is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Yu, Shang‐Fan, Bing Zheng, MaryAnn Go, et al.. (2015). A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Clinical Cancer Research. 21(14). 3298–3306. 125 indexed citations

2.

Polson, Andrew G., Bing Zheng, MaryAnn Go, et al.. (2013). Abstract 4634: Anthracycline based antibody-drug conjugates (ADCs) for the treatment of non-Hodgkin's lymphoma are effective in cell lines resistant to auristatin based ADCs.. Cancer Research. 73(8_Supplement). 4634–4634. 1 indexed citations

3.

Elkins, Kristi, Bing Zheng, MaryAnn Go, et al.. (2012). FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma. Molecular Cancer Therapeutics. 11(10). 2222–2232. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact